Recombinant FOLR1 (Farletuzumab Biosimilar) antibody

Catalog No. ABIN7581415

The Human Monoclonal anti-FOLR1 (Farletuzumab Biosimilar) antibody has been validated for ELISA, FACS, Func, BLI and SPR. It is suitable to detect FOLR1 (Farletuzumab Biosimilar) in samples from Human.

Quick Overview for Recombinant FOLR1 (Farletuzumab Biosimilar) antibody (ABIN7581415)

Target: FOLR1 (Farletuzumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This FOLR1 (Farletuzumab Biosimilar) antibody is un-conjugated

Application: ELISA, Flow Cytometry (FACS), Functional Studies (Func), Bio-Layer Interferometry (BLI), Surface Plasmon Resonance (SPR)

Product Details anti-FOLR1 (Farletuzumab Biosimilar) Antibody

Expression System: CHO Cells

Purpose: Anti-FOLR1 / FRA Reference Antibody (farletuzumab)

Sequence: EVQLVESGGG VVQPGRSLRL SCSASGFTFS GYGLSWVRQA PGKGLEWVAM ISSGGSYTYY ADSVKGRFAI SRDNAKNTLF LQMDSLRPED TGVYFCARHG DDPAWFAYWG QGTPVTVSSA STKGPSVFPL APSSKSTSGG TAALGCLVKD YFPEPVTVSW NSGALTSGVH TFPAVLQSSG LYSLSSVVTV PSSSLGTQTY ICNVNHKPSN TKVDKKVEPK SCDKTHTCPP CPAPELLGGP SVFLFPPKPK DTLMISRTPE VTCVVVDVSH EDPEVKFNWY VDGVEVHNAK TKPREEQYNS TYRVVSVLTV LHQDWLNGKE YKCKVSNKAL PAPIEKTISK AKGQPREPQV YTLPPSRDEL TKNQVSLTCL VKGFYPSDIA VEWESNGQPE NNYKTTPPVL DSDGSFFLYS KLTVDKSRWQ QGNVFSCSVM HEALHNHYTQ KSLSLSPGK,DIQLTQSPSS LSASVGDRVT ITCSVSSSIS SNNLHWYQQK PGKAPKPWIY GTSNLASGVP SRFSGSGSGT DYTFTISSLQ PEDIATYYCQ QWSSYPYMYT FGQGTKVEIK RTVAAPSVFI FPPSDEQLKS GTASVVCLLN NFYPREAKVQ WKVDNALQSG NSQESVTEQD SKDSTYSLSS TLTLSKADYE KHKVYACEVT HQGLSSPVTK SFNRGEC

Characteristics: Anti-FOLR1 Reference Antibody (farletuzumab) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 144.12 kDa.

Purity: >95 %

Isotype: IgG1

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Comment:

Therapeutic Agents by Target and Mechanism: FOLR1 antagonist

Restrictions: For Research Use only

Handling

Format: Lyophilized

Concentration: 1 mg/mL

Buffer: 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2

Storage: 4 °C,-80 °C

Storage Comment: +4°C,-80°C

Target Details for FOLR1 (Farletuzumab Biosimilar)

Target: FOLR1 (Farletuzumab Biosimilar)

Target Type: Biosimilar

Molecular Weight: 144.12 kDa

UniProt: P15328